CANCER CONSULT New edition covering the specialties of hematology, oncology and cellular therapy, now in two volumes
Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy, Second Edition includes hundreds of answers to practice-based questions covering the new principles of diagnosis, classification, staging, treatment, and outcomes in the rapidly advancing field of cancer. This textbook series also provides expert guidance in the areas of cancer-related uncertainties and controversies, including experience-based discussions. The book’s smaller size allows for easy access during medical rounds. This volume also includes:
Up-to-date clinically relevant information on the very latest topics such as molecular techniques, targeted therapies, immunotherapy, BMT, CAR T-cell therapy and translational cancer research Sections on ALL, AML, myeloid neoplasms, CLL, Hodgkin’s and Non-Hodgkin’s lymphomas, amongst other topics Streamlined, engaging content to make finding information easier and less time consuming for the reader Concise and practical expert perspectives that reference key studies References to the latest NCCN, ESMO, ASH, ASTCT, EBMT and other national guidelines
With its powerful focus on pragmatic clinical diagnostic, therapeutic and prognostic approaches, Cancer Consult: Expertise in Clinical Practice, Volume 2: Neoplastic Hematology & Cellular Therapy, Second Edition will help keep hematology, oncology and cellular therapy practitioners up-to-date, bridging the gaps between journal and reference literature, conferences, and their existing knowledge base. It also offers clinicians, trainees, and fellows an excellent opportunity to enhance their preparation for the ABIM, hematology and oncology fellowship and recertification exams.
Edited by:
Syed A. Abutalib (Midwestern Regional Medical Center Cancer Treatment Centers of America IL USA),
Maurie Markman,
M.D. (Cancer Treatment Centers of America,
Part of City of Hope,
USA),
James O. Armitage (University of Nebraska Medical Center,
Omaha,
NE),
Kenneth C. Anderson (Harvard Medical School,
Boston,
MA),
Hope S. Rugo
Imprint: John Wiley & Sons Inc
Country of Publication: United States
Edition: 2nd edition
Dimensions:
Height: 244mm,
Width: 168mm,
Spine: 46mm
Weight: 1.361kg
ISBN: 9781119823124
ISBN 10: 1119823129
Pages: 864
Publication Date: 15 December 2023
Audience:
Professional and scholarly
,
Undergraduate
Format: Paperback
Publisher's Status: Active
Editors Volume 2 xii Preface xiii Author Bios xv Acknowledgement xvii Volume 1: Solid Tumors & Supportive Care Volume 1 Editors: Syed A. Abutalib, Maurie Markman, Al B. Benson III, and Hope S. Rugo Part 1 Acute Lymphoblastic Leukemia in Adults 1 1 Prognostic Markers and Models in Acute Lymphoblastic Leukemia 3 Dieter Hoelzer 2 Acute Lymphoblastic Leukemia—Treatment and Outcomes in B-ALL 11 Vijaya Raj Bhatt, Prajwal Dhakal, and Syed A. Abutalib 3 T Cell Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma 27 Syed A. Abutalib and Daniel J. DeAngelo 4 Minimal Residual Disease in Acute Lymphoblastic Leukemia 51 Caner Saygin, Sarah Monick, and Wendy Stock 5 Hematopoietic Transplantation and Cellular Therapy in Acute Lymphoblastic Leukemia 63 Yael Morgenstern, Netanel A. Horowitz, and Jacob M. Rowe Part 2 Acute Myeloid Leukemia in Adults 81 6 Prognosis in Acute Myeloid Leukemia: Beyond Cytogenetics 83 Caner Saygin and Lucy A. Godley 7 Young Adults with Acute Myeloid Leukemia 93 Sangeetha Venugopal and Farhad Ravandi 8 Older Adults with Acute Myeloid Leukemia 103 Mary-Elizabeth Percival and Elihu Estey 9 Acute Promyelocytic Leukemia 113 Eytan M. Stein and Martin S. Tallman 10 Measurable Residual Disease in Acute Myeloid Leukemia 121 Marie Bill and Hans Beier Ommen 11 Hematopoietic Cell Transplantation and Cellular Therapy in Acute Myeloid Leukemia 133 Piyanuch Kongtim and Stefan O. Ciurea Part 3 Myelodysplastic Syndromes and Familial Myeloid Neoplasms 147 12 Diagnosis of Myelodysplastic Syndromes 149 Jay Yang, Vijendra Singh, Ali Gabali, and Charles A. Schiffer 13 Treatment of Myelodysplastic Syndromes 165 Rami S. Komrokji 14 Hematopoietic Cell Transplantation and Cellular Therapy in Myelodysplastic Syndromes 179 Ibrahim Yakoub-Agha 15 Familial Myeloid Neoplasms—When to Suspect and What to Do? 191 Ryan J. Stubbins, Amy M. Trottier , Simone Feurstein, and Lucy A. Godley Part 4 Myeloproliferative Neoplasms 211 16 Chronic Myeloid Leukemia: Chronic Phase Disease 213 Jerald P. Radich 17 Chronic Myeloid Leukemia: Advance Phases of the Disease 221 Michael J. Mauro 18 Chronic Myeloid Leukemia: Treatment Safety During Reproductive Age and Pregnancy 229 Michael J. Mauro 19 Chronic Myeloid Leukemia: Cessation of Therapy 235 Anand A. Patel and Richard A. Larson 20 Hematopoietic Cell Transplantation in Chronic Myeloid Leukemia 243 Jerald P. Radich 21 Polycythemia Vera 255 Prithviraj Bose and Srdan Verstovsek 22 Essential Thrombocythemia 265 Paola Guglielmelli and Alessandro Maria Vannucchi 23 Primary Myelofibrosis 275 Douglas Tremblay, Sangeetha Venugopal, John Mascarenhas, and Ruben Mesa 24 Hematopoietic Cell Transplantation and Cellular Therapy in Primary and Post ET/PV Myelofibrosis 287 Jerry Luo, Irum Khan, and Damiano Rondelli 25 Chronic Myelomonocytic Leukemia 305 Mrinal M. Patnaik 26 Eosinophilic Myeloproliferative Disorders 315 Jason Gotlib Part 5 Chronic Lymphocytic and Other Leukemias 331 27 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 333 Jayastu Senapati, Nitin Jain, and Susan O'Brien 28 Hematopoietic Cell Transplantation and Cellular Therapy in Chronic Lymphocytic Leukemia 345 Ajay Major, Michael R. Bishop, and Peter A. Riedell 29 Prolymphocytic Leukemia 357 Dima El-Sharkawi and Claire Dearden 30 Hairy Cell Leukemia 371 Justin M. Watts and Martin S. Tallman Part 6 Hodgkin Lymphoma 385 31 Classic Hodgkin Lymphoma 387 Christopher R. D'Angelo, James O. Armitage, and Nancy L. Bartlett 32 Nodular Lymphocyte-Predominant Hodgkin Lymphoma 401 Dennis A. Eichenauer 33 Hematopoietic Cell Transplantation and Cellular Therapy in Hodgkin Lymphoma 408 Narendranath Epperla, Alex F. Herrera, and Matthew Mei Part 7 Non-Hodgkin's Lymphomas 417 34 Pitfalls in the Diagnosis of Non-Hodgkin's Lymphomas 419 Carmen Barcena and Laurence de Leval 35 Follicular Lymphoma 435 Danielle Wallace, Nancy Torres, and Carla Casulo 36 Mantle Cell Lymphoma 447 Christina Poh and Stephen D. Smith 37 Marginal Zone Lymphoma 455 Erin Mulvey, Wayne Tam, and Peter Martin 38 Hematopoietic Cell Transplantation and Cellular Therapy in Indolent Non-Hodgkin's Lymphomas 471 Karthik Nath and Craig S. Sauter 39 Diffuse Large B Cell Lymphoma 485 Alessia Castellino and Grzegorz S. Nowakowski 40 Hematopoietic Cell Transplantation and Cellular Therapy in Diffuse Large B Cell Lymphoma 499 Shreya Desai, Syed Maaz Tariq, Arjun Patel, Istvan Redei, and Syed A. Abutalib 41 Primary Mediastinal Large B Cell Lymphoma 515 Alessandro Broccoli and Pier Luigi Zinzani 42 Double-Hit and Double-Expressor Lymphomas 525 David A. Russler-Germain and Brad S. Kahl 43 Transformed Lymphoma 539 Frederique St-Pierre and Jane N. Winter 44 Burkitt Lymphoma 555 Mark Roschewski and Wyndham Wilson 45 Primary and Secondary CNS Lymphomas 563 Leon D. Kaulen, Nicholas A. Blondin, Fred H. Hochberg, and Joachim M. Baehring 46 HIV-Associated Lymphoma 579 Elif Yilmaz and Kieron Dunleavy 47 Waldenström's Macroglobulinemia 589 Morie A. Gertz 48 Primary Cutaneous Lymphomas 599 Nicholas A. Trum, Jasmine Zain, Steven T. Rosen, and Christiane Querfeld 49 Mycosis Fungoides and Sézary Syndrome 635 Robert Stuver, Alison Moskowitz, Sarah Noor, and Steven M. Horwitz 50 Peripheral T-Cell Lymphoma 647 Avyakta Kallam and James O. Armitage Part 8 Plasma Cell Neoplasms and Related Disorders 659 51 Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma 661 Francesco Maura, Dickran Kazandjian, and Ola Landgren 52 Risk Stratification Including Measurable Residual Disease in Multiple Myeloma 673 Charalampos Charalampous and Shaji Kumar 53 Newly Diagnosed Multiple Myeloma: Transplant Eligible 687 Sagar Lonial 54 Newly Diagnosed Multiple Myeloma: Transplant Ineligible 699 Daniele Derudas and Claudio Cerchione 55 Relapsed/Refractory Multiple Myeloma 713 Neha Korde and Saad Z. Usmani 56 Light-chain (AL) Amyloidosis 727 Vaishali Sanchorawala 57 Bispecific T Cell Engager and Cell Based Immune Therapy in Multiple Myeloma 739 Meera Mohan, Parameswaran Hari, and Saurabh Chhabra Part 9 Special Issues in Neoplastic Hematology and Cellular Therapy 751 58 Treatment of Lymphomas During Pregnancy 753 Kieron Dunleavy, Emanuele Zucca, and Fedro A. Peccatori 59 Complications and Management of CAR T Cell Therapy 767 Radowan A. Elnair and Matthew A. Lunning 60 Acute Graft-versus-Host Disease 781 Aaron Etra, Uroosa Ibrahim, Jacques Azzi, and John E. Levine 61 Chronic Graft-versus-Host Disease 793 Andrew Trunk and Daniel R. Couriel Index 809
Syed A. Abutalib, MD, is Co-Director of Hematology and Stem Cell Transplantation and Clinical Director of NMDP® Apheresis Center at the Midwest Branch of Cancer Treatment Centers of America, (CTCA), Part of City of Hope. Maurie Markman, MD, is President of Medicine & Science, Cancer Treatment Centers of America, Part of City of Hope. James O. Armitage, MD, is the Joe Shapiro Professor of Medicine at University of Nebraska Medical Center and has served as Dean for College of Medicine and Chairman of Internal Medicine. He is past President of both the ASCO and the ASTCT. Kenneth C. Anderson, MD, is the Kraft Family Professor of Medicine at Harvard Medical School, as well as Director of the LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. He is past President of ASH.
